SAVA Q1 2023 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$116M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$22M

Operating Income

-$27M

Net Income

-$24M

EPS (Diluted)

$-0.52

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$673,000

Balance Sheet

Total Assets

$218M

Total Liabilities

$14M

Stockholders' Equity

$204M

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$22M	-$15M	-48.4%
Operating Income	-$27M	-$18M	-48.8%
Net Income	-$24M	-$18M	-38.5%